MDMark S. Daskin

Mark S. Daskin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mark S. Daskin has a total of 123 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The benefits (or detriments) of adapting to demand disruptions in a hospital pharmacy with supply chain disruptions

    by Lauren L Czerniak, Mariel S Lavieri, Mark S Daskin, Eunshin Byon, Karl Renius, Burgunda V Sweet, Jennifer Leja, Matthew A Tupps

    Supply chain disruptions and demand disruptions make it challenging for hospital pharmacy managers to determine how much inventory to have on-hand. Having insufficient inventory leads to drug shortages, while having excess inventory leads to drug waste. To mitigate drug shortages and waste, hospital pharmacy managers can implement inventory policies that account for supply chain disruptions and adapt these inventory policies over time to respond to demand disruptions. Demand disruptions were prevalent during the Covid-19 pandemic. However, it remains unclear how a drug’s shortage-waste weighting (i.e., concern for shortages versus concern for waste) as well as the duration of and time between supply chain disruptions influence the benefits (or detriments) of adapting to demand disruptions. We develop an adaptive inventory system (i.e., inventory policies change over time) and conduct an extensive numerical analysis using real-world demand data from the University of Michigan’s Central Pharmacy to address this research question. For a fixed mean duration of and mean time between supply chain disruptions, we find a drug’s shortage-waste weighting dictates the magnitude of the benefits (or detriments) of adaptive inventory policies. We create a ranking procedure that provides a way of discerning which drugs are of most concern and illustrates which policies to update given that a limited number of inventory policies can be updated. When applying our framework to over 300 drugs, we find a decision-maker needs to update a very small proportion of drugs (e.g.,\(<5\%\)) at any point in time to get the greatest benefits of adaptive inventory policies.


  • Open Access

    Mitigation strategies against supply disruption risk: a case study at the Ford Motor Company

    by Ece Sanci, Mark S. Daskin, Young-Chae Hong, Steve Roesch, Don Zhang

    Supply chains are exposed to different risks, which can be mitigated by various strategies based on the characteristics and needs of companies. In collaboration with Ford, we develop a decision support framework to choose the best mitigation strategy against supply disruption risk, especially for companies operating with a small supplier base and low inventory levels. Our framework is based on a multistage stochastic programming model which incorporates a variety of plausible strategies, including reserving backup capacity from the primary supplier, reserving capacity from a secondary supplier, and holding backup inventory. We reflect disruption risk into the framework through decision makers’ input on the time to recover and the disruption probability. Our results demonstrate that relying on the strategy which is optimal when there is no disruption risk can increase the expected total cost substantially in the presence of disruption risk. However, this increase can be reduced significantly by investing in the mitigation strategy recommended by our framework. Our results also show that this framework removes the burden of estimating the time to recover and the disruption probability precisely since there is often a small loss associated with using another strategy that is optimal in the neighbourhood of the estimated values.


  • Incentivizing resilient supply chain design to prevent drug shortages: policy analysis using two- and multi-stage stochastic programs

    by Emily L. Tucker, Mark S. Daskin, Burgunda V. Sweet, Wallace J. Hopp

    Supply chain disruptions have caused hundreds of shortages of medically-necessary drugs since 2011. Once a disruption occurs, the industry is limited in its ability to adapt, and improving strategic resiliency decisions is important to preventing future shortages. Yet, many shortages have been of low-margin, generic injectable drugs, and it is an open question whether resiliency is optimal. It is also unknown what policies would be effective at inducing companies to be resilient. To study these questions, we develop new supply chain design models that consider disruptions and recovery over time. The first model is a two-stage stochastic program which selects the configuration of suppliers, plants, and lines. The second is a multi-stage stochastic program which selects the configuration and target safety stock level. We then overlay incentives and regulations to change the market conditions and evaluate their effects on two generic oncology drug supply chains. We find that profit-maximizing firms may maintain vulnerable supply chains without intervention. Shortages may be reduced with: moderate failure-to-supply penalties; mandatory supply chain redundancy; substantial amounts of inventory; and/or large price increases. We compare policies by evaluating the societal costs to reduce the expected shortages to 2% and 5% of demand.


  • Open Access

    Life and expectations post-kidney transplant: a qualitative analysis of patient responses

    by Emily L. Tucker, Abigail R. Smith, Mark S. Daskin, Hannah Schapiro, Sabrina M. Cottrell, Evelyn S. Gendron, Peg Hill-Callahan, Alan B. Leichtman, Robert M. Merion, Stephen J. Gill, et al.

    The effect of a kidney transplant on a recipient extends beyond the restoration of kidney function. However, there is limited qualitative analysis of recipient perspectives on life following transplantation, particularly in the United States. To understand the full patient experience, it is necessary to understand recipient views on life adjustments after kidney transplantation, medical management, and quality of life. This could lead to improvements in recipient care and sense of well-being. We conducted a paper-based survey from March 23 to October 1, 2015 of 476 kidney transplant recipients at the University of Michigan Health System in Ann Arbor, Michigan. We analyzed their open-ended responses using qualitative research methods. This is a companion analysis to a previous quantitative report on the closed-ended responses to that survey. Common themes relating to changes following transplantation included: improvements in quality of life, a return to normalcy, better health and more energy. Concerns included: duration of graft survival, fears about one day returning to dialysis or needing to undergo another kidney transplant, comorbidities, future quality of life, and the cost and quality of their healthcare. Many recipients were grateful for their transplant, but some were anxious about the burdens transplantation placed on their loved ones. While most recipients reported meaningful improvements in health and lifestyle after kidney transplantation, a minority of participants experienced declines in energy or health status. Worries about how long the transplant will function, future health, and cost and quality of healthcare are prevalent. Future research could study the effects of providing additional information, programs, and interventions following transplantation that target these concerns. This may better prepare and support kidney recipients and lead to improvements in the patient experience.


  • Comparison of patient and provider goals, expectations, and experiences following kidney transplantation

    by Kayse Lee Maass, Abigail R. Smith, Emily L. Tucker, Hannah Schapiro, Sabrina M. Cottrell, Evelyn Gendron, Peg Hill-Callahan, Stephen J. Gill, Mark S. Daskin, Robert M. Merion, et al.


  • Location Analysis and Network Design

    by Mark S. Daskin, Kayse Lee Maass


  • The trade-off between the median and range of assigned demand in facility location models

    by Mark S. Daskin, Emily L. Tucker

    In this paper, we present an extension of the classic p-median facility location model. The new formulation allows the user to trace the trade-off between the demand-weighted average distance (the traditional p-median objective) and the range in assigned demand. We extend the model to incorporate additional constraints that significantly reduce the computation time associated with the model. We also outline a genetic algorithm-based approach for solving the problem. The paper shows that significant reductions in the range in assigned demand are possible with relatively minor degradations in the average distance metric. The paper also shows that the genetic algorithm does very well at identifying the approximate trade-off curve. The model and algorithms were tested on real-life data-sets ranging in size from 33 nodes to 880 nodes.


  • A cyclic allocation model for the inventory-modulated capacitated location problem

    by Kayse Lee Maass, Mark S. Daskin

    Hard capacity constraints have been used for decades in facility location modelling and planning. However, such constraints are unrealistic as a variety of operational tools can be used to extend capacity in the short term. To address this, the Inventory-Modulated Capacitated Location Problem (IMCLP) uses inventory as a method of mitigating the hard capacity constraints, but enforces single sourcing. In this paper, we examine a cyclic, day-specific allocation approach to assigning demand sites to processing facilities in the IMCLP. This enables the model to develop a day-of-the-week allocation policy that considers day-to-day variations in the daily processing capacity levels of a set of candidate processing facilities and/or systematic day-to-day demand variations. We demonstrate that allowing demands at a particular site to be allocated to multiple processing facilities in such a manner can be a cost-effective operational tool.